-
1 Comment
THC Biomed Intl Ltd is currently in a long term downtrend where the price is trading 8.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.3.
THC Biomed Intl Ltd's total revenue sank by 50.1% to $622K since the same quarter in the previous year.
Its net income has dropped by 884.9% to $-692K since the same quarter in the previous year.
Finally, its free cash flow fell by 501.8% to $-118K since the same quarter in the previous year.
Based on the above factors, THC Biomed Intl Ltd gets an overall score of 1/5.
CurrencyCode | EUR |
---|---|
Industry | Drug Manufacturers-Specialty & Generic |
Sector | Healthcare |
ISIN | CA87243W1032 |
Exchange | F |
Market Cap | 6M |
---|---|
Target Price | None |
Dividend Yield | 0.0% |
Beta | 0.64 |
PE Ratio | None |
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for TFHD.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024